Related references
Note: Only part of the references are listed.In vitro and in vivo evaluation of 211At-labeled fibroblast activation protein inhibitor for glioma treatment
Huan Ma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Cell cycle control in cancer
Helen K. Matthews et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals
Feize Li et al.
CHINESE CHEMICAL LETTERS (2022)
Current Status of Radiopharmaceutical Therapy
Sara St James et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
Bryce J. B. Nelson et al.
PHARMACEUTICS (2021)
Production, purification and availability of 211At: Near term steps towards global access
Yutian Feng et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The Hopeful Eight
Romain Eychenne et al.
PHARMACEUTICS (2021)
Intraperitoneal α-Emitting Radioimmunotherapy with 211At in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose Estimations
Andreas Hallqvist et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Flaxseed extract induces apoptosis in human breast cancer MCF-7 cells
Tingyan Hu et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
Bogdan Mitran et al.
CANCERS (2019)
Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning
Marcelo Tatit Sapienza et al.
CLINICS (2019)
Astatine-211 imaging by a Compton camera for targeted radiotherapy
Yuto Nagao et al.
APPLIED RADIATION AND ISOTOPES (2018)
One-step labelling of a novel small-molecule peptide with astatine-211: preliminary evaluation in vitro and in vivo
Weihao Liu et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2018)
Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides
Hojjat Bazzazi et al.
JOURNAL OF THEORETICAL BIOLOGY (2018)
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Mehran Makvandi et al.
TARGETED ONCOLOGY (2018)
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways
Alessandro Allegra et al.
TOXICOLOGY IN VITRO (2018)
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?
Alicia Vall-Sagarra et al.
PHARMACEUTICALS (2018)
Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD
Jingjing Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
211At labeled substance P (5-11) as potential radiopharmaceutical for glioma treatment
Monika Lyczko et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
In vitro polyphenol effects on apoptosis: An update of literature data
Valeria Curti et al.
SEMINARS IN CANCER BIOLOGY (2017)
Radiolabeled peptides: current and new perspectives
Marta Opalinska et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl) Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
Ana P. Kiess et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Berry anthocyanins reduce proliferation of human colorectal carcinoma cells by inducing caspase-3 activation and p21 upregulation
Sirajudheen Anwar et al.
MOLECULAR MEDICINE REPORTS (2016)
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
Damian J. Green et al.
BLOOD (2015)
Absorbed Doses and Risk Estimates of 211At-MX35 F(ab′)2 in Intraperitoneal Therapy of Ovarian Cancer Patients
Elin Cederkrantz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors
Simone Zanella et al.
CHEMISTRYOPEN (2015)
Astatine-211 labeling: a study towards automatic production of astatinated antibodies
Emma Aneheim et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2015)
The role of β3-integrins in tumor angiogenesis: context is everything
Stephen D. Robinson et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and αvβ3 integrin
Niv Papo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Astatine-211: Production and Availability
Michael R. Zalutsky et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Rotenone Induces Apoptosis in MCF-7 Human Breast Cancer Cell-Mediated ROS Through JNK and p38 Signaling
Yea-Tzy Deng et al.
MOLECULAR CARCINOGENESIS (2010)
Cooperation between integrin alpha(nu)beta(3) and VEGFR2 in angiogenesis
Payaningal R. Somanath et al.
ANGIOGENESIS (2009)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
18F-labeled BBN-RGD heterodimer for prostate cancer imaging
Zi-Bo Li et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Astatine-211 labeling of insulin: Synthesis and preliminary evaluation in vivo and in vitro
Ning Liu et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2007)
Protection by tropolones against H2O2-induced DNA damage and apoptosis in cultured Jurkat cells
PT Doulias et al.
FREE RADICAL RESEARCH (2005)
Share Paper
